Skip to content

Analysis of Clinical Characteristics of Hemodialysis Patients With Omicron Infection

Analysis of Clinical Characteristics of Hemodialysis Patients With Omicron Infection

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05559138
Enrollment
260
Registered
2022-09-29
Start date
2022-07-01
Completion date
2022-08-01
Last updated
2022-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Keywords

hemodialysis

Brief summary

By collecting the clinical data of hemodialysis patients with Omicron infection in RenJi Hospital from April 7, 2022 to June 10, 2022, the clinical characteristics of this population were analyzed. And to analyze the risk factors of different clinical outcomes according to the clinical outcome of this population.

Detailed description

This study was a single-center, retrospective, observational study. The research subjects were hemodialysis patients admitted to the Hemodialysis Center of Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine because of omicron infection during the Omicron epidemic period from April 7, 2022 to June 10, 2022. 65 cases were included in the study after excluding those patients who underwent hemodialysis due to acute kidney injury. And they were compared with 195 non-dialysis patients admitted to the hospital in the same period,who were randomly selected, according to the ratio of 1:3.

Interventions

OTHERno intervention

no intervention

Sponsors

RenJi Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hemodialysis patients due to chronic kidney disease stage 5 with omicron infection

Exclusion criteria

* Patients on hemodialysis due to acute kidney injury

Design outcomes

Primary

MeasureTime frameDescription
Viral elimination2022-4-7 to 2022-6-10both negative for ORF1ab and N genes (Ct value ≥35 by real-time PCR) in two consecutive days.

Secondary

MeasureTime frameDescription
cardiovascular events2022-4-7 to 2022-6-10including acute left heart failure, new symptomatic arrhythmias requiring drug control, acute coronary syndrome

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026